17 publications
| Name | Date | Type | Actions |
|---|---|---|---|
SALES 1st quarter 2024: €134M The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products. |
29/04/2024 | Public releases | |
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
24/04/2024 | Public releases | |
ANNUAL RESULTS 2023 (slideshow) 01.2023 Highlights |
20/03/2024 | Annual Report | |
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
20/03/2024 | Public releases | |
Annual sales 2023: €529 million Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates) |
24/01/2024 | Public releases | |
Forcyl® - a booming brand Lure (France), November 14, 2012 – Vétoquinol receives a new indication for its Forcyl® product, designed for cattle, and a new market authorization for Forcyl® Swine for pigs. |
14/11/2012 | Public releases | |
Sales momentum continues in Q3 Vétoquinol posted sales of €220.9 million for the first 9 months of 2012, up 6.2% compared to the same period last year. |
25/10/2012 | Public releases | |
Vétoquinol purchases ORSCO laboratoire vétérinaire Lure (France), September 25, 2012 – Vétoquinol announces the purchase of the entire equity of Orsco Laboratoire Vétérinaire. |
25/09/2012 | Public releases | |
Vétoquinol returns to growth Lure (France), 29 August 2012 – At its 29 August 2012 meeting, the Vétoquinol S.A. board of directors reviewed the Group results and approved the financial statements for the first six months of 2012. |
29/08/2012 | Public releases | |
Solid first half 2012 Sales First half 2012 sales reached €146.8 million, up 5.1% over first half 2011. |
17/07/2012 | Public releases |